Journal of Intellectual Property Rights

Open Access Open Access  Restricted Access Subscription Access

Whether Indian Patent Act TRIPS Compliant for Pharmaceutical Business: A Case-Based Approach


Affiliations
1 Institute of Technology and Science, Ghaziabad — 201 007, Uttar Pradesh, India., India
2 Department of Management Studies, NIT Silchar — 788 010, Assam, India., India
 

Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement was negotiated during Uruguay round and GATT was replaced by WTO. All the signatory countries had to abide to the norms of the agreement. They were asked to modify their national IP laws as per the requirement. India too incorporated the required changes and finally, Indian patent act became TRIPS compliant in 2005. Although, it was claimed that India has designed its action in a most exhaustive form still, Indian companies face lot o f litigation suits concerning infringement o f patented products. Issues were raised at international forums stating that Indian IP laws are not fully TRIPS compliant and lot o f flexibilities are given for the domestic firms which creates an unequal platform for trade. In order to reach to the substantial-conclusion on the impact of TRIPS implementation on the functioning of Indian pharmaceutical industry (IPI) and the impact it may carry with respect to the socio-economic life of the citizens of India. The study considered some of the court cases related to the infringement of patents that were raised in Indian court by MNC’s along with their decision. Through these cases and the judgements thereafter it was found out that Indian Patents Act is well in place and judiciary plays an important role in monitoring its effective implementation.

Keywords

Intellectual Property Rights,Indian Patents Act,WTO,TRIPS,Indian Pharmaceutical Industry, Innovation.
User
Notifications
Font Size

  • Smith A, The Wealth o f Nations, AnInquiry into the Nature and Causes of the Wealth of Nations, ed. Edwin A. Seligman (London: J. M. Dent, 1901), 12-15,400-401,436-437.

  • Barney Jay B, Is the resource-based “view” a useful perspective for strategic management research? Yes, Academy o f Management Review,26 (1) (2001) 41-56.

  • Hill P, Tangibles, intangibles and services: A new taxonomy for the classification of output, The Canadian journal o f economics/Revue canadienned' Economique,32 (2) (1999) 426-446.

  • Luo Y, Xue Q & Han B, How emerging market governments promote outward FDI: Experience from China, Journal o f world business,45 (1) (2010) 68-79.

  • Peter Yu, The objectives and principles of the TRIPS Agreement, The Regulation of Services and Intellectual Property, Routledge,2017, 255-322.

  • Mitsumori Y, Historical Background and Current Status of Indian Pharmaceutical Industry and Indian Patents Regime, The Indian Pharmaceutical Industry, Springer, Singapore, 2018, 9-35.

  • Danzon P M &Towse A, Differential pricing for pharmaceuticals: reconciling access, R&D and patents, International journal o f health care finance and economics, 3 (3) (2003) 183-205.

  • Kremer M, Pharmaceuticals and the developing world, Journal o f Economic perspectives,16 (4) (2002) 67-90.

  • Haley G T & Haley U C, The effects of patent-law changes on innovation: The case of India's pharmaceutical industry, Technological Forecasting and Social Change,79 (4) (2012) 607-619.

  • Vijayaraghavan B &Raghuvanshi P, Impact of the Amended Indian Patent Act on the Indian pharmaceutical industry, Journal o f Generic Medicines,5 (2) (2008) 111-119.

  • Correa C M, Intellectual Property Rights, the WTO and Developing Countries: The TRIPS Agreement and Policy Options,Zed books, 2000.

  • Dev V V, An analysis on intellectual property rights in India, Supremo Amicus,27 (2021) 513.

  • Chaudhuri S, TRIPS Agreement and amendment of Patents Act in India, Economic and Political Weekly,2002, 3354-3360.

  • Barange A & Thomas A, right to intellectual property in Novartis: Interpretation of Section 3 (d) in the Indian Patents Act 2005, Int'l JL Mgmt. & Human,,4 (2021) 3332.

  • Patel H, Modi C, Mody S, Dudhatra G, Kumar A &Chaudhari Y, Genesis and dynamics of IPR and its relevance to Indian pharmaceutical industry, International Journal fo r Agro Veterinary and Medical Sciences,6 (2) (2012) 77-90.

  • Barazza S, Incremental pharmaceutical innovation in India: The Supreme Court's judgment in the Novartis Gleevec case, Journal o f Intellectual Property Law & Practice,8 (10) (2013) 776-790.

  • Bhattacharya Swapan K, Harmonising patent laws with the TRIPS Agreement of WTO: India's stride towards globalisation of intellectual properties, International Journal o f Intellectual Property Management,1(3) (2007) 253-276.

  • Correa Carlos M, The use of compulsory licences in Latin America, Compulsory Licensing,Springer, Berlin, Heidelberg, 2015, 43-60.

  • Prasad V & Krishna B P S S, Compulsory licensing: Implications on multinational drug companies, International Journal o f Intellectual Property Management,6 (4) (2013) 247-271.


Abstract Views: 105

PDF Views: 94




  • Whether Indian Patent Act TRIPS Compliant for Pharmaceutical Business: A Case-Based Approach

Abstract Views: 105  |  PDF Views: 94

Authors

Sunil Kumar Yadav
Institute of Technology and Science, Ghaziabad — 201 007, Uttar Pradesh, India., India
Saurabh Verma
Department of Management Studies, NIT Silchar — 788 010, Assam, India., India

Abstract


Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement was negotiated during Uruguay round and GATT was replaced by WTO. All the signatory countries had to abide to the norms of the agreement. They were asked to modify their national IP laws as per the requirement. India too incorporated the required changes and finally, Indian patent act became TRIPS compliant in 2005. Although, it was claimed that India has designed its action in a most exhaustive form still, Indian companies face lot o f litigation suits concerning infringement o f patented products. Issues were raised at international forums stating that Indian IP laws are not fully TRIPS compliant and lot o f flexibilities are given for the domestic firms which creates an unequal platform for trade. In order to reach to the substantial-conclusion on the impact of TRIPS implementation on the functioning of Indian pharmaceutical industry (IPI) and the impact it may carry with respect to the socio-economic life of the citizens of India. The study considered some of the court cases related to the infringement of patents that were raised in Indian court by MNC’s along with their decision. Through these cases and the judgements thereafter it was found out that Indian Patents Act is well in place and judiciary plays an important role in monitoring its effective implementation.

Keywords


Intellectual Property Rights,Indian Patents Act,WTO,TRIPS,Indian Pharmaceutical Industry, Innovation.

References